The federal government has resumed control of the Vaccine Injury Support Program (VISP), a compensation initiative for individuals who have suffered serious injuries from Health Canada-approved vaccines, including COVID-19 vaccines. Originally managed by the consulting firm Oxaro Inc., the program faced scrutiny after a Global News investigation revealed that a disproportionate amount of funding—$33.7 million of the $50.6 million allocated—went to administrative costs rather than compensating claimants, with only $16.9 million distributed to those injured. In light of growing complaints regarding claim handling and long wait times for assessments, Health Minister Marjorie Michel announced an audit and the program’s transition back to government oversight. The new Vaccine Impact Assistance Program (VIAP) will streamline the claims process and provide real-time updates for claimants. Approximately $75 million is earmarked for the program over its first five years, with an additional $17.6 million allocated starting April 1.
Why It Matters
This story highlights the ongoing challenges and criticisms surrounding vaccine injury compensation in Canada, particularly during the COVID-19 pandemic. Prior to the establishment of VISP, Canada was the only G7 nation without a national vaccine injury compensation program, leading to concerns about the accessibility and management of such claims. With over 105 million COVID vaccine doses administered and thousands of reported adverse events, the program’s effectiveness and transparency are crucial for public trust in vaccination efforts. The transition to government management aims to address past shortcomings and improve the claims process for those affected by vaccine-related injuries.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
